Question 1

Does Blackstone own SYRE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Blackstone holds 120,177 shares of SYRE (Spyre Therapeutics), worth $10.7M.

Question 2

How many shares of SYRE does Blackstone own?

Accepted Answer

As of its Q2 2026 13F, Blackstone holds 120,177 shares of SYRE (Spyre Therapeutics).

Question 3

What is Blackstone's SYRE position worth?

Accepted Answer

As of its Q2 2026 13F, Blackstone's SYRE position is worth $10.7M.

Question 4

Is Blackstone buying or selling SYRE?

Accepted Answer

In Q2 2026, Blackstone reduced its SYRE position by 172,670 shares (-59.0%).

Question 5

When did Blackstone first buy SYRE?

Accepted Answer

Blackstone first reported SYRE in its Q4 2023 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	120,177	-59.0%	$10.7M	0.0%	$88.78	0
2026-Q1	Decreased	292,847	-41.5%	$14.8M	0.0%	$50.44	0
2025-Q4	Unchanged	500,998	0.0%	$16.4M	0.1%	$32.76	0
2025-Q3	Increased	500,998	+2.4%	$8.4M	0.0%	$16.76	28
2025-Q2	Unchanged	489,248	0.0%	$7.3M	0.0%	$14.97	0
2025-Q1	Increased	489,248	+8.9%	$7.9M	0.0%	$16.14	30
2024-Q4	Increased	449,201	+53.3%	$10.5M	0.0%	$23.28	39
2024-Q3	Unchanged	292,995	0.0%	$8.6M	0.0%	$29.41	0